Which hedge funds own AARD? AARDVARK THERAPEUTICS INC, Q2 2026 13F holders

13 tracked hedge funds disclosed a position in AARD (AARDVARK THERAPEUTICS INC) in their Q2 2026 13F filings, worth $44.7m in total. The largest holder by portfolio weight is Decheng Capital LLC at 3.1% of its book. 4 opened a new position this quarter: EcoR1 Capital, LLC, J. Goldman & Co LP, Point72 Asset Management, L.P., Marshall Wace, LLP. 5 exited: Tetragon Partners GP Ltd, Silverarc Capital Management, LLC, Gsa Capital Partners LLP.

13

Holders

Tracked managers whose filing for the quarter reports a long equity position in the security.

4

New this quarter

Holders whose previous filing (at most two quarters earlier) did not report the security.

5

Exited this quarter

Tracked managers whose previous filing reported the security and whose filing for the quarter does not.

$2.8m

Inflow, new holders

Combined value of the positions the new holders reported for the quarter.

$1.8m

Outflow, exits

Combined value the exiting managers reported for the security in their previous filing.

$44.7m

Combined value

Sum of the holders' reported positions in the security.

1.0%

Share of managers holding

Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.